Arthritis drug may improve COVID-19 survival among elderly patients, says study

In the research, published in the journal Science Advances, 83 patients with a median age of 81 and all suffering from moderate to severe COVID-19 infection were given a drug called baricitinib.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32NWEaC
via IFTTT